 |
 |
 |
 |
 |
 |
|
|
 |
|
|
 |
|
Links: • Home • About Us • Our Strategy • Executive Team • Products • Business Dev • Contact Us
|
Home > About Us |
 |
 |
|
About Us
Who We Are
- An international pharmaceutical company with a portfolio of critical care hospital products, oncology, orthopaedic, cardiovascular and gastroenterology
- Entering more than 10 countries with our products in 2007
- Experienced in all areas of international sales, legal and regulatory affairs, product licensing and training
What We Do
- Promote and distribute products directly and via preferred partners in countries outside the continental United States
- Give manufacturers/developers a single contact for international distribution allowing for international expansion and management with little investment and oversight
- Protect product intellectual property, including patents and trademarks
- Obtain country or EMEA regulatory and marketing approval
- Develop the promotional program, train the sales force, manage the sample program and create the literature
- Assist in managing government bids and tenders
- Negotiate the highest allowable prices with government authorities
- Ensure maximum market penetration for our partners' products
- Generate additional revenue and profits from unused production capacity
|

|
|
January 8, 2010 Gentalyn Receives Marketing Authorization in Chile
September 23, 2009 BurnsAdler Partners with Three Rivers Pharmaceuticals to Commercialize Infergen in Brazil and Chile
September 10, 2008 BurnsAdler Announces Named Patient Access Program for Latin America in Collaboration with DOR BioPharma
March 24, 2008 Collatamp™ EG Receives Marketing Authorization in Brazil
March 5, 2007 BurnsAdler Partners with X-GEN to Return Colistimethate for Injection to the Mexican Market
|
 |
 |
 |
 |
 |
 |
|
|
|
 |
|
© 2007 BurnsAdler Pharmaceuticals, Inc. - All rights reserved |
 |
 |
 |
 |
 |
 |
 |
| |
|